[시장보고서]세계의 혈관 접근 기기 시장 예측(-2030년) : 유형별, 삽입 경로별, 용도별, 최종사용자별

세계의 혈관 접근 기기 시장 예측(-2030년) : 유형별, 삽입 경로별, 용도별, 최종사용자별

Vascular Access Devices Market by Type(Central (PICC, Tunneled, Non-Tunnled, Port (Conventional, Power)), Peripheral(Venous (PIVC, Midline), Arterial) Intraosseous Device), Route of Insertion (IV, SC, IO), Application, End User-Global Forecast to 2030

상품코드 : 1663334 해당 상품은 즉시 배송 가능합니다

리서치사 : MarketsandMarkets

발행일 : 2025년 02월

페이지 정보 : 영문 461 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,950

￦ 7,159,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,650

￦ 9,617,000

PDF (5-user License)

PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,150

￦ 11,787,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 10,000

￦ 14,463,000

PDF (Global License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. (100% 자회사는 동일 기업으로 간주됩니다.) 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

세계의 혈관 접근 기기 시장 규모는 2024년 59억 9,000만 달러에서 2030년까지 90억 5,000만 달러에 달할 것으로 예측되며, 예측 기간에 CAGR로 7.1%의 성장이 전망됩니다.

조사 범위
조사 대상연도	2024-2030년
기준연도	2023년
예측 기간	2024-2030년
단위	달러
부문	유형, 삽입 경로, 용도, 최종사용자, 지역
대상 지역	북미, 유럽, 아시아태평양, 라틴아메리카, 중동 및 아프리카

이는 최소침습 수술의 채택이 증가함에 따라 이러한 장비에 대한 수요가 증가하고 있기 때문입니다. 또한 의료 인프라 구축에 대한 정부 지원 증가로 인해 병원이 증가하고 있으며, 이에 따라 혈관 접근 장비에 대한 수요가 증가하고 있습니다. 그러나 버스컬러 액세스 장비의 교체 및 정비와 관련된 높은 비용과 제품 리콜 증가는 시장을 억제하는 주요 요인으로 작용하고 있습니다. 또한 숙련된 의료진의 부족과 제품에 대한 지식의 부족은 시장 성장에 큰 도전이 될 것입니다. 그러나 2024-2030년의 예측 기간에는 시장 성장을 위한 환경이 조성되고 있습니다.

"유형별로는 중심정맥 접근 장비 부문이 예측 기간 중 가장 큰 점유율을 차지할 것으로 예상됩니다."

혈관 접근 장비 시장에서는 2023년 중심정맥 접근 장비 부문이 가장 큰 시장 점유율을 차지할 것으로 예상됩니다. 이는 암 및 만성 신장질환과 같은 만성질환의 유병률이 증가하고 있기 때문입니다. 화학요법 약물은 강력하고 말초 라인을 통해 투여해서는 안 되므로 대부분의 암 환자는 이러한 중심 정맥 접근 장비를 통해 화학요법을 받게 됩니다. 따라서 대부분의 의료진들은 이 장비를 선호하고 있습니다. 이처럼 이러한 질병의 유병률이 증가함에 따라 장기 치료의 필요성이 증가하여 혈관 접근 장비 시장에 대한 수요가 증가하고 있습니다. 또한 중심정맥 접근 장비는 다른 혈관 접근 장비에 비해 부작용이 적기 때문에 이 부문의 성장에 박차를 가하고 있습니다.

"투약 부문이 시장에서 가장 큰 점유율을 차지합니다."

항생제 치료, 통증 관리, 화학요법 등 장기 투약이 필요한 질환으로 인한 입원이 증가함에 따라 투약 부문이 가장 큰 시장 점유율을 차지하고 있습니다. 예를 들어 한 연구 논문에 따르면 암 환자의 최소 25%가 화학요법을 받고 있으며, 이로 인해 이식형 포트, 말초삽입형 중심정맥카테터, 터널형 카테터에 대한 수요가 증가하고 있다고 합니다. 또한 혈액투석에 사용되는 터널형 카테터의 채택이 증가하면서 시장 성장을 가속하고 있습니다. 이러한 장비는 대체품에 비해 장비 삽입을 위한 사전 절차가 필요하지 않기 때문입니다.

"지역별로는 아시아태평양이 시장 점유율 2위를 차지했습니다."

아시아태평양은 혈관 접근 장비 시장에서 두 번째로 큰 지역 시장이며, 예측 기간 중 가장 높은 CAGR로 성장할 것으로 예상됩니다. 이는 이 지역 전체에서 만성질환의 유병률이 증가하고 노인 인구가 증가하고 있기 때문입니다. 예를 들어 아시아개발은행(Asia Development Bank)에 따르면 2050년까지 아시아태평양의 인구 4명 중 1명이 60세 이상이 될 것으로 예상되며, 이는 예측 기간 중 시장 성장에 기여할 것으로 예상됩니다. 아시아태평양에는 일본, 중국, 중국, 인도, 호주, 한국, 기타 아시아태평양이 포함됩니다. 이 중 중국은 2023년 가장 큰 시장 점유율을 차지했습니다. 이는 노인 인구 증가, 암 환자 수 증가, 병원 확장이 시장 성장에 기여하고 있기 때문입니다. 예를 들어 CEIC의 데이터에 따르면 중국의 병원 수는 2022년 36,976개에서 2023년 38,400개로 증가했습니다. 병원 수가 증가함에 따라 환자를 지원하는 바스큘러 액세스 장비에 대한 수요도 지속적으로 증가하고 있습니다.

세계의 혈관 접근 기기 시장에 대해 조사분석했으며, 주요 촉진요인과 억제요인, 경쟁 구도, 향후 동향 등의 정보를 제공하고 있습니다.

혈관 접근 기기 시장 개요
북미의 혈관 접근 기기 시장 : 최종사용자별, 국가별(2023년)
혈관 접근 기기 시장의 지역적 스냅숏(2023년)
지역 구성 : 혈관 접근 기기 시장(2024-2030년)
혈관 접근 기기 시장 : 신흥 시장 vs. 선진 시장(2024년·2030년)

제5장 시장 개요

서론
시장 역학
- 촉진요인
- 억제요인
- 기회
- 과제
기술 분석
- 주요 기술
- 보완 기술
- 인접 기술
산업 동향
- 저침습 혈관 접근 수술
- 카테터 재료와 코팅의 혁신
밸류체인 분석
에코시스템 분석
공급망 분석
무역 분석
- HS 코드 901839의 수입 데이터
- HS 코드 901839의 수출 데이터
Porter's Five Forces 분석
주요 이해관계자와 구입 기준
규제 분석
- 규제기관, 정부기관, 기타 조직
- 규제 구조
특허 분석
가격 분석
- 혈관 접근 기기의 가격 동향 : 주요 기업별(2021-2023년)
- 혈관 접근 기기의 가격 동향 : 지역별(2021-2023년)
주요 컨퍼런스와 이벤트(2025-2026년)
인접 시장의 분석
미충족 요구/최종사용자 기대
고객 비즈니스에 영향을 미치는 동향/혼란
투자와 자금조달 시나리오
혈관 접근 기기 시장에 대한 AI/생성형 AI의 영향

제6장 혈관 접근 기기 시장 : 유형별

서론
중심 정맥 액세스 디바이스
- 말초 삽입형 중심 정맥 카테터
- 터널형 카테터
- 비터널형 카테터
- 이식형 포트
말초혈관 액세스 디바이스
- 말초정맥 액세스 디바이스
- 말초동맥 액세스 디바이스
액세서리
골내 혈관 접근 기기

제7장 혈관 접근 기기 시장 : 삽입 경로별

서론
정맥내 삽입 경로
피하 삽입 경로
골내 삽입 경로

제8장 혈관 접근 기기 시장 : 용도별

서론
투약
- 화학요법
- 기타 투약
수분과 영양 투여
수혈
진단·검사

제9장 혈관 접근 기기 시장 : 최종사용자별

서론
병원
- 공립 병원
- 사립 병원
진료소·외래 케어 센터
기타 최종사용자

제10장 혈관 접근 기기 시장 : 지역별

서론
북미
- 북미의 거시경제 전망
- 미국
- 캐나다
유럽
- 유럽의 거시경제 전망
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
아시아태평양
- 아시아태평양의 거시경제 전망
- 중국
- 인도
- 일본
- 호주
- 한국
- 기타 아시아태평양
라틴아메리카
- 라틴아메리카의 거시경제 전망
- 브라질
- 멕시코
- 기타 라틴아메리카
중동 및 아프리카
- 중동 및 아프리카의 거시경제 전망
- GCC 국가
- 기타 중동 및 아프리카

제11장 경쟁 구도

서론
주요 참여 기업의 전략/강점
매출 분석(2019-2023년)
시장 점유율 분석(2023년)
기업 평가 매트릭스 : 주요 기업(2023년)
기업 평가 매트릭스 : 스타트업/중소기업(2023년)
기업의 평가와 재무 지표
브랜드/제품 비교
경쟁 시나리오

제12장 기업 개요

주요 기업
- BECTON, DICKINSON AND COMPANY
- TELEFLEX INCORPORATED
- ICU MEDICAL
- NIPRO
- ANGIODYNAMICS, INC.
- VYGON
- TERUMO CORPORATION
- MEDTRONIC PLC
- COOK
- B. BRAUN SE
- MERIT MEDICAL SYSTEMS, INC.
- AMECATH
- MEDICAL COMPONENTS, INC.
- HEALTHLINE MEDICAL PRODUCTS
- ACCESS VASCULAR, INC.
기타 기업
- ARGON MEDICAL DEVICES
- PAKUMEDMEDICAL PRODUCTS GMBH
- GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
- PFM MEDICAL GMBH
- MEDI-TECH DEVICES PVT. LTD.
- KIMAL
- POLYMEDICURE
- DELTAMED
- NEWTECH MEDICAL DEVICES PVT. LTD.
- SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

제13장 부록

KSA

영문 목차

영문목차

The global Vascular access device market is projected to reach USD 9.05 billion by 2030 from USD 5.99 billion in 2024, at a CAGR of 7.1% during the forecast period.

Scope of the Report
Years Considered for the Study	2024-2030
Base Year	2023
Forecast Period	2024-2030
Units Considered	Value (USD)
Segments	Type, Route of Insertion, Application, End User, and Region
Regions covered	North America, Europe, Asia Pacific, Latin America, Middle East & Africa (GCC Countries, RoMEA)

This is due to increasing adoption of minimally invasive procedure, as the adoption increases the demand for these devices rises. Additionally, increasing government support to build infrastructure for healthcare is increasing, thus rising the number of hospitals, consequently increasing the demand for the vascular access device. However, the high cost associated with replacement and maintenance of vascular access devices and increasing product recalls are the major restraint to the market. Additionally, the shortage of trained healthcare professionals & limited knowledge about the products is major challenge for the market growth. But is creating a conducive environment for market expansion over the forecast period of 2024-2030.

"The central venous access device segment of vascular access device market by type to hold largest position forecast period."

Based on the product, the vascular access device market is divided into central venous access device, peripheral vascular access device, intraosseous access device, and accessories. Among these, in 2023 central venous access device segment account for the largest market share of XX% in vascular access device market. This is due to the rising prevalence of chronic diseases such as cancer, chronic kidney disease. Majority of the cancer patients will be given chemotherapy through these central venous access devices, as the chemotherapy drug are potent and should not be given through peripheral line. Thus, majority of the healthcare professionals prefer these devices. Thus, as the prevalence of these diseases is increasing the need for long-term treatment is rising, consequently increasing the demand for vascular access device market. Additionally, central venous access device has lesser adverse reactions compared to other vascular access devices thus fueling the segmental growth.

"The drug administration segment accounts for the largest market share in vascular access device market."

Based on application, the vascular access device market is segmented into drug administration, fluid and nutrition administration, blood transfusion, and diagnostics & testing. The drug administration segment accounts for the largest market share in vascular access device market due to increasing hospitalization for diseases which require long term drug administration such as antibiotic therapy, pain management, chemotherapy and others. For instance, as per a research article, at least 25% of cancer patients undergo chemotherapy, thus increasing demand for implantable ports, peripherally inserted central catheters and tunneled catheters. Additionally, increasing adoption of tunneled catheters for hemodialysis is supporting the market growth, as these devices does not require any prior procedure to insert the device compared to their alternatives. This segment is again divided into chemotherapy and other drug administration. Among these, in 2023, other drug administration segment to hold the largest market share of XX% in vascular access device market by drug application. This is due to increased prevalence of diseases such as infectious diseases, chronic inflammatory diseases, cardiovascular diseases and among others.

"Asia Pacific accounted for the second largest share of the vascular access device market by region."

The global vascular access device market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Asia Pacific is the second largest regional market for vascular access device equipment and is estimated to grow at the highest CAGR during the forecast period. This is due to increasing prevalence of chronic diseases and rising geriatric population across the region. For instance, as per Asia Development Bank, by 2050, one in four people in Asia and Pacific will be over 60 years old thus contributing to the market growth across the forecast period. Asia Pacific region includes Japan, China, India, Australia, South Korea and Rest of Asia Pacific. Among these, China accounts for the largest market share in vascular access device market in 2023. This is due to increasing aging population and rising number of cancer cases and hospital expansions contribute to the growing market. For instance, as per CEIC data, number of hospitals in China increased from 36,976 in 2022 to 38400 in 2023. As the number of hospitals increases, the demand for vascular access devices continues to grow, to support patients.

A breakdown of the primary participants referred to for this report is provided below:

By Company Type: Tier 1-40%, Tier 2-30%, and Tier 3- 30%
By Designation: C-level-50%, Director-level-30% and Others-20%
By Region: North America-30%, Europe-25%, Asia Pacific-20%, Latin America- 15%, and Middle east and Africa - 10%

Note 1: Note: Companies are classified into tiers based on their total revenue. As of 2023, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs.

Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.

The major players operating in the vascular access device market are Becton, Dickinson and Company (US), Teleflex Incorporated (US), ICU Medical, Inc. (US), B. Braun SE (Germany), AngioDynamics, Inc. (US), Medtronic, Plc (Ireland), Merit Medical Systems Inc. (US), Terumo Corporation (Japan), Nipro (Japan), Vygon (France), AMECATH (Egypt), Medical Components, Inc. (US), Healtline Medical Products (US), Cook (US), and Access Vascular, Inc. (US)

Research Coverage

This report studies the vascular access device market based on product, type, end user and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five major regions (and the respective countries in these regions).

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Analysis of Key divers (Growing prevalence of lifestyle diseases, increasing number of chemotherapy procedures, growing use of vascular access devices in pediatric patients), restraints (High cost associated with placement and maintenance of vascular access device, product recalls and failures), Challenge (Shortage of skilled professionals, risks associated with vascular access devices), opportunity (Technological Advancements, growth in number of hospitals)
Market Penetration: Comprehensive information on the product portfolios offered by the top players in the vascular access device market
Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the vascular access device market
Market Development: Comprehensive information on lucrative emerging regions
Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the pain management devices market
Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

1 INTRODUCTION

1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 STUDY SCOPE
- 1.3.1 SEGMENTS CONSIDERED & GEOGRAPHICAL SPREAD
- 1.3.2 INCLUSIONS & EXCLUSIONS
- 1.3.3 YEARS CONSIDERED
- 1.3.4 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

2.1 RESEARCH DATA
- 2.1.1 SECONDARY DATA
  - 2.1.1.1 Objectives of secondary research
  - 2.1.1.2 Key secondary sources
  - 2.1.1.3 Key data from secondary sources
- 2.1.2 PRIMARY DATA
  - 2.1.2.1 Key primary sources
  - 2.1.2.2 Key objectives of primary research
  - 2.1.2.3 Key data from primary sources
  - 2.1.2.4 Key industry insights
2.2 MARKET SIZE ESTIMATION
- 2.2.1 SUPPLY-SIDE ANALYSIS (REVENUE SHARE ANALYSIS)
- 2.2.2 TOP-DOWN APPROACH
- 2.2.3 COMPANY PRESENTATIONS AND PRIMARY INTERVIEWS
- 2.2.4 DEMAND-SIDE ANALYSIS
2.3 GROWTH FORECAST
2.4 DATA TRIANGULATION
2.5 MARKET RANKING ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
- 2.7.1 METHODOLOGY-RELATED LIMITATIONS
- 2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

4.1 VASCULAR ACCESS DEVICES MARKET OVERVIEW
4.2 NORTH AMERICA: VASCULAR ACCESS DEVICES MARKET, BY END USER AND COUNTRY, 2023
4.3 GEOGRAPHIC SNAPSHOT OF VASCULAR ACCESS DEVICES MARKET, 2023
4.4 REGIONAL MIX: VASCULAR ACCESS DEVICES MARKET, 2024-2030 (USD MILLION)
4.5 VASCULAR ACCESS DEVICES MARKET: EMERGING VS. DEVELOPED MARKETS, 2024 VS. 2030 (USD MILLION)

5 MARKET OVERVIEW

5.1 INTRODUCTION
5.2 MARKET DYNAMICS
- 5.2.1 DRIVERS
  - 5.2.1.1 Growing prevalence of lifestyle diseases
  - 5.2.1.2 Increasing popularity of chemotherapy procedures among cancer patients
  - 5.2.1.3 Rising use of vascular access devices among pediatric patients
- 5.2.2 RESTRAINTS
  - 5.2.2.1 High cost of installation and maintenance of vascular access devices
  - 5.2.2.2 Rising product recalls and failures
- 5.2.3 OPPORTUNITIES
  - 5.2.3.1 Technological advancements
  - 5.2.3.2 Increasing number of hospitals and expanding patient pool
- 5.2.4 CHALLENGES
  - 5.2.4.1 Shortage of skilled healthcare professionals
  - 5.2.4.2 Risks associated with use of vascular access devices
5.3 TECHNOLOGY ANALYSIS
- 5.3.1 KEY TECHNOLOGIES
  - 5.3.1.1 Imaging and navigation technologies
  - 5.3.1.2 Catheter securement and stabilization technologies
- 5.3.2 COMPLEMENTARY TECHNOLOGIES
  - 5.3.2.1 AI and ML
- 5.3.3 ADJACENT TECHNOLOGIES
  - 5.3.3.1 Infection control technologies
5.4 INDUSTRY TRENDS
- 5.4.1 MINIMALLY INVASIVE VASCULAR ACCESS PROCEDURES
- 5.4.2 INNOVATIONS IN CATHETER MATERIALS AND COATINGS
5.5 VALUE CHAIN ANALYSIS
5.6 ECOSYSTEM ANALYSIS
- 5.6.1 ROLE IN ECOSYSTEM
5.7 SUPPLY CHAIN ANALYSIS
5.8 TRADE ANALYSIS
- 5.8.1 IMPORT DATA FOR HS CODE 901839
- 5.8.2 EXPORT DATA FOR HS CODE 901839
5.9 PORTER'S FIVE FORCES ANALYSIS
- 5.9.1 THREAT OF NEW ENTRANTS
- 5.9.2 THREAT OF SUBSTITUTES
- 5.9.3 BARGAINING POWER OF BUYERS
- 5.9.4 BARGAINING POWER OF SUPPLIERS
- 5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 KEY STAKEHOLDERS & BUYING CRITERIA
- 5.10.1 KEY STAKEHOLDERS IN BUYING PROCESS
- 5.10.2 KEY BUYING CRITERIA
5.11 REGULATORY ANALYSIS
- 5.11.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
- 5.11.2 REGULATORY FRAMEWORK
  - 5.11.2.1 North America
    - 5.11.2.1.1 US
    - 5.11.2.1.2 Canada
  - 5.11.2.2 Europe
  - 5.11.2.3 Asia Pacific
  - 5.11.2.4 Latin America
  - 5.11.2.5 Middle East & Africa
5.12 PATENT ANALYSIS
- 5.12.1 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.13 PRICING ANALYSIS
- 5.13.1 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY KEY PLAYER, 2021-2023
- 5.13.2 INDICATIVE PRICING TREND OF VASCULAR ACCESS DEVICES, BY REGION, 2021-2023
5.14 KEY CONFERENCES & EVENTS, 2025-2026
5.15 ADJACENT MARKET ANALYSIS
- 5.15.1 VASCULAR CLOSURE DEVICES MARKET
5.16 UNMET NEEDS/END-USER EXPECTATIONS
5.17 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
5.18 INVESTMENT & FUNDING SCENARIO
5.19 IMPACT OF AI/GEN AI ON VASCULAR ACCESS DEVICES MARKET

6 VASCULAR ACCESS DEVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 CENTRAL VENOUS ACCESS DEVICES
- 6.2.1 PERIPHERALLY INSERTED CENTRAL CATHETERS
  - 6.2.1.1 Better durability and increased clinical utility for extended treatment plans to drive segment
- 6.2.2 TUNNELED CATHETERS
  - 6.2.2.1 Lower risk of infection and superior longevity to support segment growth
- 6.2.3 NON-TUNNELED CATHETERS
  - 6.2.3.1 Non-tunneled catheters to be used in critical cases with limited peripheral access
- 6.2.4 IMPLANTABLE PORTS
  - 6.2.4.1 Implantable conventional ports
    - 6.2.4.1.1 Ability to provide reliable venous access with minimal maintenance to spur adoption
  - 6.2.4.2 Implantable power injectable ports
    - 6.2.4.2.1 Ability to accommodate high-flow fluids and increased demand for chemotherapy to propel market growth
6.3 PERIPHERAL VASCULAR ACCESS DEVICES
- 6.3.1 PERIPHERAL VENOUS ACCESS DEVICES
  - 6.3.1.1 Peripheral intravenous catheters
    - 6.3.1.1.1 Cost-effectiveness, ease of placement, and compatibility with different treatments to augment segment growth
  - 6.3.1.2 Midline catheters
    - 6.3.1.2.1 Ability to provide reliable medium-term intravenous access from one to four weeks to aid segment growth
  - 6.3.1.3 Butterfly/Winged steel needles
    - 6.3.1.3.1 Precision and comfort in short-term venous access procedures to drive segment
- 6.3.2 PERIPHERAL ARTERIAL ACCESS DEVICES
  - 6.3.2.1 Critical role in continuous hemodynamic monitoring and blood sampling in acute care settings to propel segment growth
6.4 ACCESSORIES
- 6.4.1 NEED FOR ENHANCED FUNCTIONALITY, PATIENT SAFETY, AND PROCEDURAL EFFICIENCY TO DRIVE MARKET
6.5 INTRAOSSEOUS VASCULAR ACCESS DEVICES
- 6.5.1 CRITICAL ROLE IN EMERGENCY SITUATIONS TO FUEL UPTAKE IN HIGH-STRESS HEALTHCARE FACILITIES

7 VASCULAR ACCESS DEVICES MARKET, BY ROUTE OF INSERTION

7.1 INTRODUCTION
7.2 INTRAVENOUS ROUTE OF INSERTION
- 7.2.1 RISING NEED FOR ADMINISTERING ESSENTIAL TREATMENTS DURING ACUTE CARE TO AID MARKET GROWTH
7.3 SUBCUTANEOUS ROUTE OF INSERTION
- 7.3.1 REDUCED INFECTION RISK, BETTER PATIENT COMFORT, AND MINIMAL MAINTENANCE TO AUGMENT MARKET GROWTH
7.4 INTRAOSSEOUS ROUTE OF INSERTION
- 7.4.1 NEED FOR RAPID AND RELIABLE ACCESS IN CRITICAL EMERGENCIES TO FUEL UPTAKE

8 VASCULAR ACCESS DEVICES MARKET, BY APPLICATION

8.1 INTRODUCTION
8.2 DRUG ADMINISTRATION
- 8.2.1 CHEMOTHERAPY
  - 8.2.1.1 Increased incidence of cancer and advancements in oncology care to drive segment
- 8.2.2 OTHER DRUG ADMINISTRATION
8.3 FLUID & NUTRITION ADMINISTRATION
- 8.3.1 INCREASING NEED FOR INTRAVENOUS THERAPY IN CHRONIC DISEASES TO SPUR MARKET GROWTH
8.4 BLOOD TRANSFUSION
- 8.4.1 FREQUENT NEED FOR BLOOD TRANSFUSION FOR THALASSEMIA AND LYMPHOMA TO BOOST MARKET GROWTH
8.5 DIAGNOSTICS & TESTING
- 8.5.1 INCREASING RELIANCE ON ACCURATE DIAGNOSTIC IMAGING, FLUID TESTING, AND PATIENT MONITORING TO AID MARKET GROWTH

9 VASCULAR ACCESS DEVICES MARKET, BY END USER

9.1 INTRODUCTION
9.2 HOSPITALS
- 9.2.1 PUBLIC HOSPITALS
  - 9.2.1.1 Increasing demand for affordable healthcare services in emerging economies to drive segment
- 9.2.2 PRIVATE HOSPITALS
  - 9.2.2.1 Rising demand for advanced healthcare services and high-quality treatment options to drive market
9.3 CLINICS & AMBULATORY CARE CENTERS
- 9.3.1 INCREASING DEMAND FOR OUTPATIENT PROCEDURES AND COST-EFFECTIVE TREATMENTS TO BOOST SEGMENT GROWTH
9.4 OTHER END USERS

10 VASCULAR ACCESS DEVICES MARKET, BY REGION

10.1 INTRODUCTION
10.2 NORTH AMERICA
- 10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
- 10.2.2 US
  - 10.2.2.1 US to dominate North American vascular access devices market during forecast period
- 10.2.3 CANADA
  - 10.2.3.1 Rising cancer prevalence and advanced research initiatives to propel market growth
10.3 EUROPE
- 10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
- 10.3.2 GERMANY
  - 10.3.2.1 Rising obesity rates and growing geriatric population to augment market growth
- 10.3.3 UK
  - 10.3.3.1 Increased disease burden to fuel uptake for advanced vascular access devices for better treatment procedures
- 10.3.4 FRANCE
  - 10.3.4.1 Presence of vascular access device manufacturers and technological advancements to fuel market growth
- 10.3.5 ITALY
  - 10.3.5.1 Strong government healthcare policies to boost market growth
- 10.3.6 SPAIN
  - 10.3.6.1 Growing geriatric population and rising incidence of chronic diseases to fuel market growth
- 10.3.7 REST OF EUROPE
10.4 ASIA PACIFIC
- 10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
- 10.4.2 CHINA
  - 10.4.2.1 Advanced healthcare infrastructure and high geriatric population to support market growth
- 10.4.3 INDIA
  - 10.4.3.1 Rising governmental health expenditure and increasing incidence of chronic diseases to fuel market growth
- 10.4.4 JAPAN
  - 10.4.4.1 Increased geriatric population and high prevalence of cancer to drive market
- 10.4.5 AUSTRALIA
  - 10.4.5.1 Increased demand for hemodialysis and advancements in healthcare infrastructure to propel market growth
- 10.4.6 SOUTH KOREA
  - 10.4.6.1 Rising burden of chronic diseases and increasing aged population to boost market growth
- 10.4.7 REST OF ASIA PACIFIC
10.5 LATIN AMERICA
- 10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
- 10.5.2 BRAZIL
  - 10.5.2.1 Growing cancer burden and rising need for long-term treatment for chronic patients to drive market
- 10.5.3 MEXICO
  - 10.5.3.1 Increasing focus on dialysis for patients with chronic kidney diseases to drive adoption of advanced vascular access devices
- 10.5.4 REST OF LATIN AMERICA
10.6 MIDDLE EAST & AFRICA
- 10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
- 10.6.2 GCC COUNTRIES
  - 10.6.2.1 Increasing healthcare investments and rising prevalence of chronic diseases to propel market growth
- 10.6.3 REST OF MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
- 11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN VASCULAR ACCESS DEVICES MARKET
11.3 REVENUE ANALYSIS, 2019-2023
11.4 MARKET SHARE ANALYSIS, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
- 11.5.1 STARS
- 11.5.2 EMERGING LEADERS
- 11.5.3 PERVASIVE PLAYERS
- 11.5.4 PARTICIPANTS
- 11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
  - 11.5.5.1 Company footprint
  - 11.5.5.2 Region footprint
  - 11.5.5.3 Type footprint
  - 11.5.5.4 Route of insertion footprint
  - 11.5.5.5 Application footprint
  - 11.5.5.6 End-user footprint
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
- 11.6.1 PROGRESSIVE COMPANIES
- 11.6.2 RESPONSIVE COMPANIES
- 11.6.3 DYNAMIC COMPANIES
- 11.6.4 STARTING BLOCKS
- 11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
  - 11.6.5.1 Detailed list of key startup/SME players
  - 11.6.5.2 Competitive benchmarking of key emerging players/startups
11.7 COMPANY VALUATION & FINANCIAL METRICS
- 11.7.1 FINANCIAL METRICS
- 11.7.2 COMPANY VALUATION
11.8 BRAND/PRODUCT COMPARISON
11.9 COMPETITIVE SCENARIO
- 11.9.1 PRODUCT LAUNCHES & APPROVALS
- 11.9.2 DEALS
- 11.9.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

12.1 KEY PLAYERS
- 12.1.1 BECTON, DICKINSON AND COMPANY
  - 12.1.1.1 Business overview
  - 12.1.1.2 Products offered
  - 12.1.1.3 Recent developments
    - 12.1.1.3.1 Deals
  - 12.1.1.4 MnM view
    - 12.1.1.4.1 Key strengths
    - 12.1.1.4.2 Strategic choices
    - 12.1.1.4.3 Weaknesses & competitive threats
- 12.1.2 TELEFLEX INCORPORATED
  - 12.1.2.1 Business overview
  - 12.1.2.2 Products offered
  - 12.1.2.3 Recent developments
    - 12.1.2.3.1 Product launches
    - 12.1.2.3.2 Other developments
  - 12.1.2.4 MnM view
    - 12.1.2.4.1 Key strengths
    - 12.1.2.4.2 Strategic choices
    - 12.1.2.4.3 Weaknesses & competitive threats
- 12.1.3 ICU MEDICAL
  - 12.1.3.1 Business overview
  - 12.1.3.2 Products offered
  - 12.1.3.3 Recent developments
    - 12.1.3.3.1 Deals
  - 12.1.3.4 MnM view
    - 12.1.3.4.1 Key strengths
    - 12.1.3.4.2 Strategic choices
    - 12.1.3.4.3 Weaknesses & competitive threats
- 12.1.4 NIPRO
  - 12.1.4.1 Business overview
  - 12.1.4.2 Products offered
  - 12.1.4.3 MnM view
    - 12.1.4.3.1 Key strengths
    - 12.1.4.3.2 Strategic choices
    - 12.1.4.3.3 Weaknesses & competitive threats
- 12.1.5 ANGIODYNAMICS, INC.
  - 12.1.5.1 Business overview
  - 12.1.5.2 Products offered
  - 12.1.5.3 Recent developments
    - 12.1.5.3.1 Product approvals
    - 12.1.5.3.2 Deals
  - 12.1.5.4 MnM view
    - 12.1.5.4.1 Key strengths
    - 12.1.5.4.2 Strategic choices
    - 12.1.5.4.3 Weaknesses & competitive threats
- 12.1.6 VYGON
  - 12.1.6.1 Business overview
  - 12.1.6.2 Products offered
- 12.1.7 TERUMO CORPORATION
  - 12.1.7.1 Business overview
  - 12.1.7.2 Products offered
- 12.1.8 MEDTRONIC PLC
  - 12.1.8.1 Business overview
  - 12.1.8.2 Products offered
- 12.1.9 COOK
  - 12.1.9.1 Business overview
  - 12.1.9.2 Products offered
- 12.1.10 B. BRAUN SE
  - 12.1.10.1 Business overview
  - 12.1.10.2 Products offered
  - 12.1.10.3 Recent developments
    - 12.1.10.3.1 Product launches & approvals
    - 12.1.10.3.2 Deals
- 12.1.11 MERIT MEDICAL SYSTEMS, INC.
  - 12.1.11.1 Business overview
  - 12.1.11.2 Products offered
  - 12.1.11.3 Recent developments
    - 12.1.11.3.1 Deals
- 12.1.12 AMECATH
  - 12.1.12.1 Business overview
  - 12.1.12.2 Products offered
- 12.1.13 MEDICAL COMPONENTS, INC.
  - 12.1.13.1 Business overview
  - 12.1.13.2 Products offered
- 12.1.14 HEALTHLINE MEDICAL PRODUCTS
  - 12.1.14.1 Business overview
  - 12.1.14.2 Products offered
- 12.1.15 ACCESS VASCULAR, INC.
  - 12.1.15.1 Business overview
  - 12.1.15.2 Products offered
12.2 OTHER PLAYERS
- 12.2.1 ARGON MEDICAL DEVICES
- 12.2.2 PAKUMEDMEDICAL PRODUCTS GMBH
- 12.2.3 GUANGDONG BAIHE MEDICAL TECHNOLOGY CO., LTD.
- 12.2.4 PFM MEDICAL GMBH
- 12.2.5 MEDI-TECH DEVICES PVT. LTD.
- 12.2.6 KIMAL
- 12.2.7 POLYMEDICURE
- 12.2.8 DELTAMED
- 12.2.9 NEWTECH MEDICAL DEVICES PVT. LTD.
- 12.2.10 SHANGHAI PUYI MEDICAL INSTRUMENTS CO., LTD.

13 APPENDIX

13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS